Clinical Trials on Upper Respiratory Tract Infections in Austria

Total 3046 results

Elisabethinen Hospital

Unknown

Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation

Stem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle Training

Austria
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Completed

Recombinant H7 Hemagglutinin Influenza Vaccine Trial (FLU007)

Influenza, Avian

Australia
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
GlaxoSmithKline

Completed

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Infections, Respiratory Tract

United States
University Hospital of Cologne
Bencard Allergie GmbH

Completed

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Perennial Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis

Austria
Respivert Ltd

Completed

Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis

Seasonal Allergic Rhinitis

Austria
Medical University of Vienna
AstraZeneca

Completed

Kinetics of Nasal Cytokine Responses to Mechanical Stimulation

Allergic Rhinitis Due to Grass Pollen | Allergic Asthma

Austria
Marinomed Biotech AG

Completed

Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
Research Consult GmbH

Completed

Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Seasonal

Austria
Medical University Innsbruck
Queen's University, Belfast; Cystic Fibrosis Foundation; European Cystic Fibrosis...

Active, not recruiting

COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF

Covid19 | Cystic Fibrosis

Austria
Abbott

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Influenza

Australia
The University of Queensland
European Society of Intensive Care Medicine

Completed

International Study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) (PneumoINSPIRE)

Nosocomial Pneumonia

Australia, Greece
Medical University of Vienna

Active, not recruiting

Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients (BOOST_TX_SubA)

COVID-19

Austria
Marinomed Biotech AG

Completed

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
GlaxoSmithKline

Completed

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Rhinitis, Allergic, Perennial and Seasonal

Austria
Medical University of Graz

Completed

Acupuncture for Prevention of Recurrent Urinary Tract Infections. (SARUTI)

Recurrent Urinary Tract Infection

Austria
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Faes Farma, S.A.

Completed

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber

Seasonal Allergic Rhinitis

Austria
Celtaxsys, Inc.
Linear Clinical Research; CPR Pharma Services Pty Ltd, Australia; Clinical Network...

Completed

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

Pulmonary Inflammation

Australia
Ology Bioservices

Completed

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

Influenza

Austria, Germany, Poland
Sven Schneider, MD

Not yet recruiting

Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects (AllergyAge)

Allergic Rhinitis | Allergic Conjunctivitis

Austria
University of Sydney
Telethon Kids Institute; Bionet Co., Ltd; Technovalia; Institute for Clinical Pathology...

Completed

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (COVALIA)

SARS-CoV2 COVID-19

Australia
Medical University of Vienna

Active, not recruiting

Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients (BOOST_TX)

COVID-19

Austria
RDC Clinical Pty Ltd

Recruiting

Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms

Long Covid19

Australia
Adjuvance Technologies, Inc.

Terminated

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Pertussis

Australia
Beyond Air Inc.

Unknown

A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients

Cystic Fibrosis | Mycobacterium Avium Complex | Non-Tuberculous Mycobacterial Pneumonia | Mycobacterial Pneumonia | Mycobacterium Abscessus Infection

Australia
Emergent BioSolutions

Completed

Universal Influenza A Vaccine in Healthy Adults (EBS-UFV-001)

Human Influenza

Australia
DiaSorin Molecular LLC

Not yet recruiting

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Coronavirus Disease 2019 | Influenza A | Respiratory Syncytial Virus (RSV) | Adenovirus | Influenza Type B | Enterovirus | Mycoplasma Pneumonia | Bordetella Parapertussis Infection | Chlamydia Pneumonia | Para Influenza | Bordetella Pertussis Infection, Respiratory

Australia
Technovalia, Pty Ltd
Chulalongkorn University; Southern Star Research Pty Ltd.; BioNet-Asia

Active, not recruiting

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

COVID-19, SARS CoV 2 Infection

Australia
Seqirus

Completed

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults

Influenza Caused by the Novel Influenza A (H1N1) Virus

Australia
Codagenix, Inc

Completed

Intramuscular CodaVax-H1N1 in Healthy Adults

Influenza, Human

Australia
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (COVID-19)

COVID-19 | SARS CoV 2 Infection

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B (PIPET B)

Pandemic Influenza

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza (PIPET C)

Pandemic Influenza

Australia
Western Sydney Local Health District
Centre Of Research Excellence in Tuberculosis Control

Recruiting

The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis (BLAST)

Tuberculosis, Pulmonary

Australia
Octapharma

Completed

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection

Covid19

Austria, France, Germany, Sweden
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza (PIPET A)

Pandemic Influenza

Australia
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)

Influenza

Australia
Codagenix, Inc

Completed

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Influenza

Australia
Seqirus

Completed

A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population

Influenza

Australia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Influenza | Orthomyxoviridae Infections

Australia
Medical University of Graz
Medical University Innsbruck; Austrian Science Fund (FWF); AGES

Completed

Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria (SARIVA)

COVID-19

Austria
Murdoch Childrens Research Institute
Bill and Melinda Gates Foundation; Royal Children's Hospital

Completed

BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)

COVID-19 | Corona Virus Infection | Coronavirus Disease 2019 (COVID-19) | Respiratory Illness

Australia, Brazil, Netherlands, Spain, United Kingdom
Codagenix, Inc

Completed

Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray

Influenza

Australia
Respirio Pty Ltd

Completed

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Influenza

Australia
Telethon Kids Institute
National Health and Medical Research Council, Australia; Sydney Children's... and other collaborators

Completed

Pertussis Immunisation and Food Allergy (PIFA)

Food Allergy

Australia
Arcturus Therapeutics, Inc.
Novotech (Australia) Pty Limited; Seqirus

Recruiting

Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults

Influenza, Human

Australia
Hospital Hietzing

Unknown

Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients With COPD

COPD

Austria

Clinical Trials on Upper Respiratory Tract Infections in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations